Literature DB >> 8265688

Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats.

D W Johnson1, S D Glick.   

Abstract

Morphine administered at high doses produces a biphasic locomotor effect, characterized by an initial locomotor depression, followed a short time later by hyperlocomotion. Prior exposure to morphine produces tolerance to the motor-depressive effects and sensitization to the motor-activating effects of morphine. Little is known of the neurochemical changes that occur to produce tolerance and sensitization to morphine. In the present study, we developed a morphine pretreatment regimen in rats that produced both tolerance and sensitization to a high (30 mg/kg) dose of morphine. Using in vivo microdialysis, we then measured dopamine (DA), dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) release in the nucleus accumbens (NAC) and striatum (STR) in morphine- and saline-pretreated rats after acute morphine administration. In morphine-tolerant/sensitized rats, basal DA concentrations in the NAC were higher and levels of DOPAC and HVA in the NAC after acute morphine injection were greater compared to controls. These results suggest that the NAC, but not the STR, may be important in mediating tolerance and sensitization to opiates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265688     DOI: 10.1016/0091-3057(93)90362-w

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

Review 1.  Microdialysis and the neurochemistry of addiction.

Authors:  Mary M Torregrossa; Peter W Kalivas
Journal:  Pharmacol Biochem Behav       Date:  2007-09-12       Impact factor: 3.533

2.  Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning.

Authors:  C L Patti; S R Kameda; R C Carvalho; A L Takatsu-Coleman; G B Lopez; S T Niigaki; V C Abílio; R Frussa-Filho; R H Silva
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

Review 3.  Drug wanting: behavioral sensitization and relapse to drug-seeking behavior.

Authors:  Jeffery D Steketee; Peter W Kalivas
Journal:  Pharmacol Rev       Date:  2011-04-13       Impact factor: 25.468

4.  Sex differences in locomotor effects of morphine in the rat.

Authors:  Rebecca M Craft; James L Clark; Stephen P Hart; Megan K Pinckney
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

5.  Reversal of oxycodone and hydrocodone tolerance by diazepam.

Authors:  Maciej Gonek; Hamid I Akbarali; Graeme Henderson; William L Dewey
Journal:  Brain Res       Date:  2017-08-19       Impact factor: 3.252

Review 6.  Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse.

Authors:  Ingo Willuhn; Matthew J Wanat; Jeremy J Clark; Paul E M Phillips
Journal:  Curr Top Behav Neurosci       Date:  2010

7.  Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.

Authors:  D P Devine; L Taylor; R K Reinscheid; F J Monsma; O Civelli; H Akil
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 8.  The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.

Authors:  M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  Role of D₁/D₂ dopamin receptors antagonist perphenazine in morphine analgesia and tolerance in rats.

Authors:  Ercan Ozdemir; Ihsan Bagcivan; Sinan Gursoy
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

Review 10.  Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Nora D Volkow; Oliver D Howes
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.